BIAL
Paulo Miguel Godinho Marques has extensive experience in the field of information systems and quality assurance, currently serving as Computer Systems Quality Assurance at Bial since September 2005. In this role, Paulo is responsible for ensuring the quality of computer systems through validation, requirements management, test preparation and execution, supplier auditing, in-company auditing, infrastructure qualification, and change management. Prior positions include Project Manager at Sol-S, Systems Analyst at Cap Gemini, Systems Programmer at Coritel, and Audiovisual Producer and Director at Onda Video. Paulo holds a degree in Information Systems from Universidade de Coimbra and an MBA in Management from Escola de Gestão do Porto.
This person is not in any offices
BIAL
Founded in 1924, BIAL’s mission is to discover, develop and provide new therapeutic solutions within the area of Health. Today, BIAL is an innovative international pharmaceutical company with products available in more than 50 countries. The company is committed to making a contribution to improve human health and quality of life for people from all over the world. Its strategic areas are Innovation, Internationalisation and Quality. Strongly committed to therapeutic innovation, and consistently investing more than 20% of its annual revenue in Research and Development (R&D), BIAL has established an ambitious R&D programme. The key focus area for the Group is neurosciences. The company headquarters are located in Portugal. BIAL has also facilities in Spain, Germany, United Kingdom, Italy, Switzerland, US, Mozambique, Angola, Panama and Ivory Coast. BIAL Group is a member of the “European Federation of Pharmaceutical Industries and Associations” (EFPIA). BIAL has also been distinguished by its support to several medical and scientific activities, namely through BIAL Foundation, having as outstanding events the BIAL Award in Biomedicine, the Prémio BIAL de Medicina Clínica and Scientific Research Grants, well recognized worldwide. For more information, please visit: www.bial.com For issues of safety or others related to product quality, please contact: pharmacovigilance@bial.com